Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.

2024年

2024年05月16日 High-mobility group box 1 fragment ameliorates chronic pancreatitis induced by caerulein in mice 

2023年

2023年06月28日 High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model 
2023年06月13日 Gene-modified blister fluid-derived mesenchymal stromal cells for treating recessive dystrophic epidermolysis bullosa 

2022年

2022年10月20日 Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a non-alcoholic steatohepatitis mouse model 
2022年09月15日 Single-cell transcriptome analysis of fractional CO 2 laser efficiency in treating a mouse model of alopecia 

2021年

2021年09月27日 Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice. 

2020年

2020年04月10日 High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRalpha-positive bone marrow cells. 
株式会社ステムリム > 論文・学術発表 > Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.